[Drug design of angiogenesis inhibitor for chondrosarcoma treatment].
Surgical operation division, National cancer center hospital, Tokyo, Japan
Mitsuharu
M
Miyagi
Akira
A
Kawai
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001859:Bone Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000378:metabolism; D002813:Chondrosarcoma / Q000098:blood supply* / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D040262:Receptors, Vascular Endothelial Growth Factor